• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Stem Cells

Magenta Therapeutics rises on Street-beating Q4

March 3, 2021 By Sean Whooley

Magenta Therapeutics (NSDQ:MGTA) shares ticked up today on fourth-quarter earnings that topped the consensus forecast. The Cambridge, Mass.-based stem cell transplantation technology developer posted losses of -$18.2 million, or -38¢ per share for the three months ended Dec. 31, 2020, marking a 21.8% bottom-line gain. Get the full story at our sister site, Drug Delivery Business […]

Filed Under: Business/Financial News, Drug-Device Combinations, MassDevice Earnings Roundup, Regenerative Medicine, Stem Cells, Wall Street Beat Tagged With: magentatherapeutics

Mayo Clinic, W.L. Gore team up on stem cell therapy treatments

December 11, 2019 By Nancy Crotti

Mayo Clinic and W. L. Gore & Associates have announced a partnership to develop implantable cell therapies to treat debilitating conditions with no cure. The for-profit company, Avobis Bio, will combine a patient’s own stem cells with bioabsorbable scaffolds to stimulate the healing of perianal fistulas, painful tunneling wounds that affect patients with Crohn’s disease. […]

Filed Under: Business/Financial News, Featured, Implants, Regenerative Medicine, Research & Development, Stem Cells, Surgical, Wound Care Tagged With: Avobis Bio, Mayo Clinic, W.L. Gore & Associates

Frequency Therapeutics registers $100m IPO

September 9, 2019 By Sean Whooley

Frequency Therapeutics has registered an initial public offering of common stock worth $100 million. Woburn, Mass.-based Frequency Therapeutics did not disclose the number of shares it seeks to sell or the price range of the offered units. The company applied to the Securities and Exchange Commission have its common stock listed on The Nasdaq Global Market […]

Filed Under: Business/Financial News, Funding Roundup, Initial Public Offering (IPO), News Well, Otolaryngology/Ear, Nose & Throat (ENT), Research & Development, Stem Cells Tagged With: Frequency Therapeutics

AxoSim touts results of nerve-on-a-chip study

July 9, 2019 By Nancy Crotti

A new study of AxoSim’s Nerve-on-a-Chip technology shows that the platform accurately provides key physiological readouts that could help speed the development of drugs to treat neurological disorders. The study also shows that Nerve-on-a-Chip technology is the first all-human in vitro model that can measure critical factors that were formerly only available using live animal models. These […]

Filed Under: Featured, Neurological, Research & Development, Stem Cells Tagged With: axosim

FDA goes after California stem cell doc for unapproved breast implant device

February 15, 2019 By Fink Densford

The FDA this week sent a warning letter to a Beverly Hills, Calif.-based surgeon for their marketing of an unapproved implantable device, dubbed the Pocket Protector, which the surgeon claims can prevent and treat capsular contracture, or scar tissue tightening, during breast implant procedures. In its letter, the federal watchdog also accuses the surgeon, Dr. […]

Filed Under: Cosmetic/Aesthetic, Featured, Food & Drug Administration (FDA), Stem Cells

RenovaCare chairman ponies up nearly $16m for wound-healing stem cell SkinGun

November 30, 2018 By Danielle Kirsh

RenovaCare (Scottsdale, Ariz.) has announced an equity financing for $15.5 million from Kalen Capital Corporation, the family office of Harmel Rayat, who is the majority shareholder and chairman of RenovaCare. The equity financing increases his family office’s total equity investment in RenovaCare to over $20 million. “Our long-term investment in RenovaCare speaks to our conviction that […]

Filed Under: Regenerative Medicine, Stem Cells Tagged With: RenovaCare

Anika collabs to develop injectable stem cell therapy for osteoarthritis

February 2, 2018 By Sarah Faulkner

Anika Therapeutics (NSDQ:ANIK) has inked an agreement with the Institute of Integrative Biology at the University of Liverpool to develop an injectable mesenchymal stem cell therapy to treat osteoarthritis. As a result of the three-year research collaboration, the group hopes to have a lead candidate that it can take into clinical trials. Get the full story at our […]

Filed Under: Drug-Device Combinations, Orthopedics, Pharmaceutical, Research & Development, Stem Cells, Wall Street Beat Tagged With: Anika Therapeutics Inc., University of Liverpool

Frequency touts first-in-human safety study for hearing loss therapy

January 2, 2018 By Sarah Faulkner

Frequency Therapeutics has finished a first-in-human study of its progenitor cell activation therapy, FX-322, in nine adults with severe to profound sensorineural hearing loss. The company’s candidate is a combination of small molecules that are designed to activate progenitor cells and trigger the formation of new hair cells in the inner ear. Get the full story […]

Filed Under: Clinical Trials, Drug-Device Combinations, Otolaryngology/Ear, Nose & Throat (ENT), Pharmaceutical, Regenerative Medicine, Stem Cells Tagged With: Frequency Therapeutics

Semma Therapeutics closes $114m round to advance cell therapy for Type I diabetes

November 30, 2017 By Sarah Faulkner

Semma Therapeutics has closed an oversubscribed $114 million Series B round to help fund the development of its encapsulated stem cell-derived islet therapy for Type I diabetes. The Cambridge, Mass.-based company reported that it plans to use the newly-acquired funds to bring its cell therapy through clinical proof-of-concept studies, as well as explore other regenerative medicine […]

Filed Under: Diabetes, Funding Roundup, Regenerative Medicine, Stem Cells Tagged With: Juvenile Diabetes Research Foundation (JDRF), Medtronic, Novartis, Semma Therapeutics

Researchers reverse diabetes in mice by infusing them with blood stem cells

November 17, 2017 By Sarah Faulkner

Researchers at Boston Children’s Hospital successfully reversed Type I diabetes in a mouse model using blood stem cells, according to a study published this week in Science Translational Medicine. The researchers used cells that were pre-treated to make more of a protein, PD-L1, which is deficient in mice and people with Type I diabetes. “There’s really a reshaping […]

Filed Under: Diabetes, Drug-Device Combinations, Pharmaceutical, Regenerative Medicine, Research & Development, Stem Cells Tagged With: Boston Children's Hospital

BrainStorm enrolls first ALS patient in late-stage NurOwn trial

October 16, 2017 By Sarah Faulkner

Brainstorm Cell Therapeutics (NSDQ:BCLI) said today that the first patients have been enrolled in its Phase III trial evaluating NurOwn as a treatment for amyotrophic lateral sclerosis, or ALS, at Massachusetts General Hospital and UC Irvine Medical Center. The trial, which is slated to enroll 200 patients, is designed to include the pre-specified patient subgroups who […]

Filed Under: Clinical Trials, Neurological, Stem Cells, Wall Street Beat Tagged With: BrainStorm Cell Therapeutics Inc.

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 17
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS